Angle-supported phakic intraocular lenses for the correction of XXXX : Three-year follow-up.

@entity1 @entity1358 @entity5862 @entity2300 @entity717 @entity1714
PURPOSE: To evaluate @entity1 safety and refractive outcomes in eyes with an angle-supported phakic intraocular lens (pIOL), and to assess the correlation between rotation and corneal endothelial cell damage. SETTING: Gimbel Eye Centres, Calgary and Edmonton, Alberta, Canada. DESIGN: Retrospective cohort study. METHODS: This study included @entity1 with moderate to high @entity1714 (range -6.50 to -19.50 diopters [D]) who received the Acrysof Cachet pIOL. Outcome measures included uncorrected distance visual acuity (UDVA), corrected distance visual acuity, manifest refraction spherical equivalent (MRSE), @entity1358 ( @entity1358 ), and @entity717 . RESULTS: This study evaluated 119 eyes of 61 @entity1 . The mean @entity1358 decrease from preoperative measurements was 3.11% (n = 46), with a mean @entity717 of 10.6 degrees (n = 35) at the 3-year postoperative visit. Of the 49 eyes at the 3-year visit measured for UDVA, 98.0% were 20/40 or better and 77.6% were 20/20 or better. The MRSE improved from a preoperative mean of -9.26 diopters (D)    2.43 (SD) (range -19.50 to -5.63 D) to -0.33    0.61 D (range -3.12 to +0.71 D) at the 3-year visit. The residual refractive error was within   0.50 D of the target refraction for 78.4% and within   1.00 D for 92.2% of the 51 eyes. The study included one bilateral pIOL removal due to endothelial cell loss, one case of @entity5862 , and one case of @entity2300 . CONCLUSIONS: No correlation between @entity717 and @entity1358 decrease was found (R(2) = 0.0143); the pIOL provided promising refractive outcomes and acceptable safety in @entity1 with moderate to high @entity1714 . FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.
